Patents by Inventor Sreenivasachary NAMPALLY

Sreenivasachary NAMPALLY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel Compounds
    Publication number: 20230391774
    Abstract: The present invention relates to novel compounds that can be employed in the treatment, alleviation or prevention of a group of diseases, disorders and or abnormality associated with misfolding of Tau protein and/or pathological aggregation of Tau (Tubulin associated unit) protein including, but not limited to, Neurofibrillary Tangles (NFTs), such as Alzheimer's disease (AD). The present invention also relates to processes for the preparation of said compounds, pharmaceutical compositions comprising said compounds, methods using said compounds, combinations comprising said compounds, medicaments containing them, and their uses in diseases, disorders and/or abnormalities associated with misfolding of Tau protein and/or pathological aggregation of Tau (Tubulin associated unit) protein.
    Type: Application
    Filed: October 11, 2021
    Publication date: December 7, 2023
    Inventors: Sreenivasachary Nampally, Emanuele Gabellieri, Veronique Dreyfus Dehlinger
  • Compounds for the treatment, alleviation or prevention of disorders associated with Tau aggregates
    Patent number: 11814378
    Abstract: The present invention relates to novel compounds that can be employed in the treatment, alleviation or prevention of a group of disorders and abnormalities associated with Tau (Tubulin associated unit) protein aggregates including, but not limited to, Neurofibrillary Tangles (NFTs), such as Alzheimer's disease (AD).
    Type: Grant
    Filed: January 9, 2020
    Date of Patent: November 14, 2023
    Assignee: AC Immune SA
    Inventors: Sreenivasachary Nampally, Emanuele Gabellieri, Jerome Molette
  • Novel Compounds for the Treatment, Alleviation or Prevention of Disorders Associated with Tau Aggregates
    Publication number: 20230255976
    Abstract: The present invention relates to novel compounds that can be employed in the treatment, alleviation or prevention of a group of disorders and abnormalities associated with Tau (Tubulin associated unit) protein aggregates including, but not limited to, Neurofibrillary Tangles (NFTs), such as Alzheimer's disease (AD).
    Type: Application
    Filed: April 4, 2023
    Publication date: August 17, 2023
    Inventors: Sreenivasachary Nampally, Emanuele Gabellieri, Jerome Molette
  • Compounds for the treatment, alleviation or prevention of disorders associated with tau aggregates
    Patent number: 11684625
    Abstract: The present invention relates to novel compounds of formula (I) that can be employed in the treatment, alleviation or prevention of a group of disorders and abnormalities associated with Tau (Tubulin associated unit) protein aggregates including, but not limited to, Neurofibrillary Tangles (NFTs), such as Alzheimer's disease (AD).
    Type: Grant
    Filed: May 30, 2019
    Date of Patent: June 27, 2023
    Assignee: AC Immune SA
    Inventors: Sreenivasachary Nampally, Emanuele Gabellieri, Jerome Molette
  • Novel Compounds for the Treatment, Alleviation or Prevention of Disorders Associated with Tau Aggregates
    Publication number: 20220127263
    Abstract: The present invention relates to novel compounds that can be employed in the treatment, alleviation or prevention of a group of disorders and abnormalities associated with Tau (Tubulin associated unit) protein aggregates including, but not limited to, Neurofibrillary Tangles (NFTs), such as Alzheimer's disease (AD).
    Type: Application
    Filed: January 29, 2020
    Publication date: April 28, 2022
    Inventors: Sreenivasachary Nampally, Emanuele Gabellieri
  • Novel Compounds for the Treatment, Alleviation or Prevention of Disorders Associated with Tau Aggregates
    Publication number: 20210267989
    Abstract: The present invention relates to novel compounds of formula (I) that can be employed in the treatment, alleviation or prevention of a group of disorders and abnormalities associated with Tau (Tubulin associated unit) protein aggregates including, but not limited to, Neurofibrillary Tangles (NFTs), such as Alzheimer's disease (AD).
    Type: Application
    Filed: May 30, 2019
    Publication date: September 2, 2021
    Inventors: Sreenivasachary Nampally, Emanuele Gabellieri, Jerome Molette
  • Novel Compounds for the Treatment, Alleviation or Prevention of Disorders Associated with Tau Aggregates
    Publication number: 20210214371
    Abstract: The present invention relates to novel compounds that can be employed in the treatment, alleviation or prevention of a group of disorders and abnormalities associated with Tau (Tubulin associated unit) protein aggregates including, but not limited to, Neurofibrillary Tangles (NFTs), such as Alzheimer's disease (AD).
    Type: Application
    Filed: May 20, 2019
    Publication date: July 15, 2021
    Inventors: Sreenivasachary Nampally, Emanuele Gabellieri, Jerome Molette, Heiko Kroth, Cedric Boudou
  • Carbazole and carboline compounds for use in the diagnosis, treatment, alleviation or prevention of disorders associated with amyloid or amyloid-like proteins
    Patent number: 10662193
    Abstract: The present invention relates to novel compounds that can be employed in the diagnosis, treatment, alleviation or prevention of a group of disorders and abnormalities associated with amyloid proteins and amyloid-like proteins, such as Alzheimer's disease. Precursors for the preparation of the compounds according to the present invention are also provided.
    Type: Grant
    Filed: January 21, 2015
    Date of Patent: May 26, 2020
    Assignees: AC IMMUNE SA, LIFE MOLECULAR IMAGING SA
    Inventors: Heiko Kroth, Sreenivasachary Nampally, Jér{hacek over (o)}me Molette, Emanuele Gabellieri, Pascal André René Benderitter, Wolfgang Froestl, Hanno Schieferstein, Andre Mueller, Heribert Schmitt-Willich, Mathias Berndt
  • Novel compounds for the treatment, alleviation or prevention of disorders associated with Tau aggregates
    Publication number: 20200148679
    Abstract: The present invention relates to novel compounds that can be employed in the treatment, alleviation or prevention of a group of disorders and abnormalities associated with Tau (Tubulin associated unit) protein aggregates including, but not limited to, Neurofibrillary Tangles (NFTs), such as Alzheimer's disease (AD).
    Type: Application
    Filed: January 9, 2020
    Publication date: May 14, 2020
    Inventors: Sreenivasachary NAMPALLY, Emanuele GABELLIERI, Jerome MOLETTE
  • Compounds for the treatment, alleviation or prevention of disorders associated with Tau aggregates
    Patent number: 10633383
    Abstract: The present invention relates to novel compounds that can be employed in the treatment, alleviation or prevention of a group of disorders and abnormalities associated with Tau (Tubulin associated unit) protein aggregates including, but not limited to, Neurofibrillary Tangles (NFTs), such as Alzheimer's disease (AD).
    Type: Grant
    Filed: March 13, 2019
    Date of Patent: April 28, 2020
    Assignee: AC Immune SA
    Inventor: Sreenivasachary Nampally
  • Novel compounds for the treatment, alleviation or prevention of disorders associated with Tau aggregates
    Publication number: 20190211012
    Abstract: The present invention relates to novel compounds that can be employed in the treatment, alleviation or prevention of a group of disorders and abnormalities associated with Tau (Tubulin associated unit) protein aggregates including, but not limited to, Neurofibrillary Tangles (NFTs), such as Alzheimer's disease (AD).
    Type: Application
    Filed: March 13, 2019
    Publication date: July 11, 2019
    Inventors: Sreenivasachary NAMPALLY, Emanuele GABELLIERI, Jerome MOLETTE
  • NOVEL IMAGING COMPOUNDS
    Publication number: 20180264146
    Abstract: The present invention relates to novel compounds that can be employed in the selective Tau detection of disorders and abnormalities associated with Tau aggregates such as Alzheimer's disease and other tauopathies using Positron Emission Tomography (PET) Imaging.
    Type: Application
    Filed: July 15, 2016
    Publication date: September 20, 2018
    Applicants: AC IMMUNE S.A., PIRAMAL IMAGING SA
    Inventors: Heiko KROTH, Sreenivasachary NAMPALLY, Jérôme MOLETTE, Emanuele GABELLIERI, Hanno SCHIEFERSTEIN, Andre MÜLLER, Heribert SCHMITT-WILLICH, Mathias BERNDT
  • Carbazole and Carboline Compounds for Use in the Diagnosis, Treatment, Alleviation or Prevention of Disorders Associated with Amyloid or Amyloid-Like Proteins
    Publication number: 20170002005
    Abstract: The present invention relates to novel compounds that can be employed in the diagnosis, treatment, alleviation or prevention of a group of disorders and abnormalities associated with amyloid proteins and amyloid-like proteins, such as Alzheimer's disease. Precursors for the preparation of the compounds according to the present invention are also provided.
    Type: Application
    Filed: January 21, 2015
    Publication date: January 5, 2017
    Inventors: Heiko KROTH, Sreenivasachary NAMPALLY, Jérôme MOLETTE, Emanuele GABELLIERI, Pascal André René BENDERITTER, Wolfgang FROESTL, Hanno SCHIEFERSTEIN, Andre MUELLER, Heribert SCHMITT-WILLICH, Mathias BERNDT